About Pacritinib
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis
Adult dose: | 100 mg orally once daily
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Diarrhea, nausea, fatigue, anemia, thrombocytopenia, elevated liver enzymes
Contraindications: | Hypersensitivity to pacritinib or any component of the formulation; severe hepatic impairment
Storage: | Store at room te
Drug Class
Janus kinase (JAK) inhibitor
Uses & Indications
Treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture
Manufacturer & Packaging
Manufacturer: CTI Biopharma, United States of America
Package Size
120's
Price & Supplier
Price in UAE: AED 113928.00
Dosage Information
Adult Dose
100 mg orally once daily
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Diarrhea, nausea, fatigue, anemia, thrombocytopenia, elevated liver enzymes
Contraindications & Precautions
Hypersensitivity to pacritinib or any component of the formulation; severe hepatic impairment
Important Warnings
Risk of serious bleeding; monitor for thrombocytopenia; liver enzyme elevations; not recommended for patients with severe hepatic impairment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.